Target intelligence / Profile preview

Contactin-associated protein 1 (CNTNAP1)

Target
CNTNAP1
Molecular classification
Cell adhesion molecule, Transmembrane protein, Neurexin family, Other
01

Overview

Contactin-associated protein 1 (CNTNAP1, also called CASPR or Paranodin) is a critical neuronal cell adhesion molecule and a key member of the neurexin family[3]. It is a large transmembrane protein, highly concentrated at the paranodal regions of myelinated axons, where it forms multiprotein complexes with contactin (a GPI-anchored protein) and neurofascin 155 on glial cells[2][3]. CNTNAP1 acts as a molecular scaffold that organizes and stabilizes the paranodal junctions, keeping sodium and potassium channels in their proper axonal domains and thus enabling rapid and efficient saltatory nerve conduction[1][2][3]. Its extracellular domain contains various protein-protein interaction modules, while its cytoplasmic tail links the complex to the axonal cytoskeleton[2]. CNTNAP1 is essential for neurodevelopment, particularly in coordinating the timing of neuron versus astrocyte differentiation[2]. Mutations in CNTNAP1 result in a range of severe congenital neuropathies, reflecting its indispensable role in nervous system structure and function[1][3]. There are no current drugs known to directly target CNTNAP1, but its disruption has been linked to diseases such as congenital hypomyelinating neuropathy and severe neurodevelopmental disabilities[3].

Other names
CASPRParanodinNRXN4Caspr1p190Neurexin IVNeurexin-4CHN3
02

Biological functions

Axon myelinationFormation and stabilization of paranodal junctionsSegregation of ion channels (saltatory conduction)Nerve impulse propagationNeuron and astrocyte differentiationMaintenance of axoglial domain organizationSynaptic signalingOther
03

Disease associations

Neurodegenerative diseaseCongenital hypomyelinating neuropathyLethal congenital contracture syndrome type 7Arthrogryposis multiplex congenitaMultiple sclerosisAutism spectrum disordersCognitive and motor impairmentOther
04

Safety considerations

Loss-of-function mutations cause severe neuropathies and neuromuscular deficits[1][3].Disruption results in impaired saltatory conduction and neurological dysfunction[2].Mutations implicated in lethal and congenital disorders[3].

Beyond the preview

Go deeper on Contactin-associated protein 1 (CNTNAP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Contactin-associated protein 1 (CNTNAP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call